Last updated: July 22, 2026
By downloading or using the “Doza” iOS application, published by Infini Consulting (trading as “Infini Apps”, RCS Paris 103 122 420, 47 rue Vivienne, 75002 Paris, France), you agree to these Terms of Use. If you do not agree, please do not use the app.
Doza is a personal tracking tool for GLP-1 treatments: dose logging, an estimated absorption curve, weight and BMI tracking, and dose reminders. All data is stored locally on your device (see the Privacy Policy).
Doza is not a medical device and does not provide medical advice. The displayed curve and levels are mathematical estimates for informational purposes only — they are not measurements of actual drug concentration. Never start, stop, or change the dosage of a treatment without the advice of a qualified healthcare professional. In case of emergency, contact your local emergency services.
Use of the app is governed by Apple's Licensed Application End User License Agreement (standard EULA). The app and all of its content (design, texts, graphics, code) remain the property of the publisher.
The app is provided “as is”. We work hard to keep it accurate and reliable, but we cannot guarantee it is free of errors. To the maximum extent permitted by applicable law, the publisher shall not be liable for any indirect damages arising from the use of the app — in particular any decision of a medical nature, which must always be made with a healthcare professional.
These terms may be updated; the date at the top indicates the latest revision. Continued use of the app after an update constitutes acceptance of the new terms.
These terms are governed by French law. Any dispute shall fall under the exclusive jurisdiction of the French courts, without prejudice to mandatory consumer protection rules.
Questions about these terms: contact@infini-apps.com
See also: Privacy Policy · Legal Notice